Patents by Inventor Weisheng Shen

Weisheng Shen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MULTI-MODALITY MOLECULAR IMAGING PROBE, AND PREPARATION METHOD AND USE THEREOF
    Publication number: 20240139348
    Abstract: Disclosed are a multi-modality molecular imaging probe, and a preparation method and use thereof. The multi-modality molecular imaging probe has an ABA structure, with a magnetic functional unit of a gadolinium complex at the center, and two identical phosphorescent functional units of an iridium complex, which are reasonably integrated into the same one complex molecule. The multi-modality molecular imaging probe simultaneously introduces two optical functional units of the iridium complex and one magnetic functional unit of a gadolinium chelate in the same one complex molecule, which exhibits magnetic-optical dual functional properties. It therefore could be used to prepare both a contrast agent for magnetic resonance imaging and an optical probe for optical imaging.
    Type: Application
    Filed: September 12, 2023
    Publication date: May 2, 2024
    Inventors: Jiaxi Ru, Xiaoliang Tang, Xiufeng Huang, Weisheng Liu, Chao Liang, Lingling Kang, Xiaofen Chen, Xian Shen
  • Pyrazole derivatives
    Patent number: 9249172
    Abstract: Disclosed are pyrazole compounds of general formula (I), wherein R, R1, Rc, Rd, Re, Rf, X, Y, Z, A and B are as defined in the application. These compounds are active as inhibitors of poly(ADP-ribose)polymerase (PARP) and are useful in methods for treating diseases or conditions mediated by PARP, including breast cancer and malignant melanoma.
    Type: Grant
    Filed: May 23, 2011
    Date of Patent: February 2, 2016
    Assignees: HANDE PHARMA LIMITED, HANDE STARLAKE BIOSCIENXE CO., LTD.
    Inventors: Chenxi Li, Weisheng Shen, Yang Fang, Xiaoyong Le
  • PYRAZOLE DERIVATIVES
    Publication number: 20130142757
    Abstract: Disclosed are compounds of general formula (I), wherein R, R1, Rc, Rd, Re, Rf, X, Y, Z, A and B are as defined in the application.
    Type: Application
    Filed: May 23, 2011
    Publication date: June 6, 2013
    Applicants: Hande Starlake Bioscience Co., Ltd., Hande Pharma Limited
    Inventors: Chenxi LI, Weisheng Shen, Yang Fang, Xiaoyong Le